Detalhe da pesquisa
1.
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design.
Semin Cancer Biol
; 52(Pt 2): 158-165, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307568
2.
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Neuro Oncol
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452246
3.
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.
Ann Oncol
; 23(10): 2725-2730, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22565124
4.
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
Ann Oncol
; 23(7): 1687-93, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22112970
5.
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform.
Sci Rep
; 12(1): 8342, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585228
6.
Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit.
J Cancer Res Clin Oncol
; 134(6): 697-704, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18064489
7.
Systemic dissemination in cancer of unknown primary is independent of mutational inactivation of the KiSS-1 metastasis-suppressor gene.
Pathol Oncol Res
; 14(3): 239-41, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18351443
8.
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
Cancer Chemother Pharmacol
; 60(5): 733-9, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17333194